Stephen D Wiviott

Stephen D Wiviott

UNVERIFIED PROFILE

Are you Stephen D Wiviott?   Register this Author

Register author
Stephen D Wiviott

Stephen D Wiviott

Publications by authors named "Stephen D Wiviott"

Are you Stephen D Wiviott?   Register this Author

100Publications

2387Reads

-Profile Views

Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes. Reply.

N Engl J Med 2019 05;380(19):1881-1882

Brigham and Women's Hospital, Boston, MA.

View Article

Download full-text PDF

Source
http://www.nejm.org/doi/10.1056/NEJMc1902837
Publisher Site
http://dx.doi.org/10.1056/NEJMc1902837DOI Listing
May 2019

Edoxaban in atrial fibrillation patients with established coronary artery disease: Insights from ENGAGE AF-TIMI 48.

Eur Heart J Acute Cardiovasc Care 2019 Mar 24;8(2):176-185. Epub 2018 Jul 24.

1 TIMI Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/2048872618790561DOI Listing
March 2019

Classification of Deaths in Cardiovascular Outcomes Trials.

Circulation 2019 Feb;139(7):874-876

TIMI Study Group, Cardiovascular Division, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/CIRCULATIONAHA.118.038359DOI Listing
February 2019

Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes.

N Engl J Med 2019 01 10;380(4):347-357. Epub 2018 Nov 10.

From the Thrombolysis in Myocardial Infarction (TIMI) Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital (S.D.W., M.P.B., T.A.Z., J.F.K., S.A.M., D.L.B., C.T.R., M.S.S.), and the Cardiology Division, Massachusetts General Hospital (M.G.S.) - both in Boston; the Diabetes Unit, Hadassah Hebrew University Hospital, Jerusalem (I.R., O.M., A.C.); the Department of Cardiovascular Medicine, Kyoto University Graduate School of Medicine, Kyoto, Japan (E.T.K.); Li Ka Shing Knowledge Institute, St. Michael's Hospital, University of Toronto, Toronto (L.A.L.); the Division of Cardiology, University of Texas Southwestern Medical Center, Dallas (D.K.M.); Institute of Ageing and Chronic Disease, University of Liverpool, Liverpool, United Kingdom (J.P.H.W.); and AstraZeneca Gothenburg, Mölndal, Sweden (I.A.M.G.-N., M.F., P.A.J., A.-M.L.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1812389DOI Listing
January 2019

Lorcaserin and Renal Outcomes in Obese and Overweight Patients in the CAMELLIA-TIMI 61 Trial.

Circulation 2019 Jan;139(3):366-375

TIMI Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital, Boston, MA (B.M.S., E.A.B., A.Q., S.A.M., K.I., M.P.B., C.T.R., M.S.S., S.D.W.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/CIRCULATIONAHA.118.038341DOI Listing
January 2019

Lorcaserin Safety in Overweight or Obese Patients.

N Engl J Med 2019 01;380(1):100

Brigham and Women's Hospital, Boston, MA

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMc1813971DOI Listing
January 2019

Outcomes of Patients Receiving Downstream Revascularization After Initial Medical Management for Non-ST-Segment Elevation Acute Coronary Syndromes (From the TRILOGY ACS Trial).

Am J Cardiol 2018 Oct 19;122(8):1322-1329. Epub 2018 Jul 19.

Division of Cardiology, Department of Medicine, Duke University School of Medicine, Durham, North Carolina; Duke Clinical Research Institute, Duke University School of Medicine, Durham, North Carolina. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.amjcard.2018.06.052DOI Listing
October 2018

Efficacy and Safety of Further Lowering of Low-Density Lipoprotein Cholesterol in Patients Starting With Very Low Levels: A Meta-analysis.

JAMA Cardiol 2018 Sep;3(9):823-828

TIMI Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://cardiology.jamanetwork.com/article.aspx?doi=10.1001/j
Publisher Site
http://dx.doi.org/10.1001/jamacardio.2018.2258DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6233651PMC
September 2018

Cardiovascular Safety of Lorcaserin in Overweight or Obese Patients.

N Engl J Med 2018 09 26;379(12):1107-1117. Epub 2018 Aug 26.

From the Thrombolysis in Myocardial Infarction (TIMI) Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital, Boston (E.A.B., S.D.W., J.K., K.I., A.Q., M.P.B., C.T.R., M.S.S., B.M.S.); the Cardiovascular Division, University of Texas Southwestern Medical Center, Dallas (D.K.M.); the Section of Endocrinology, Yale School of Medicine, New Haven, CT (S.E.I.); the Department of Medicine, University of Minnesota, Minneapolis (C.L.F.); the Partners Clinical Research Centre, Nassau, Bahamas (C.B.); the Department of Cardiology, Postgraduate Medical School, Grochowski Hospital, Warsaw, Poland (A.B.); Cardiolink Clinical Trials, Monterrey, Mexico (A.G.-C.); McMaster University, Brampton, ON (M.G.), and the Division of Endocrinology and Metabolism, St. Michael's Hospital, University of Toronto, Toronto (L.A.L.) - both in Canada; MedStar Health Research Institute, Hyattsville, MD (N.J.W.); the Cardiology Department, Auckland City Hospital, Auckland, New Zealand (H.D.W.); Eisai, Woodcliff Lake, NJ (T.P., B.F., W.M., C.P., S.D.); National Health and Medical Research Council Clinical Trials Centre, University of Sydney, Sydney (A.C.K.); and the Translational Research Institute for Metabolism and Diabetes, Florida Hospital and the Sanford-Burnham Institute, Winter Park (S.R.S.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1808721DOI Listing
September 2018

DECLARE-TIMI 58: Participants' baseline characteristics.

Diabetes Obes Metab 2018 05 14;20(5):1102-1110. Epub 2018 Feb 14.

TIMI Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital, and Harvard Medical School, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/dom.13217DOI Listing
May 2018

Use of systemic bivalirudin with catheter-directed thrombolysis in a patient with heparin-induced thrombocytopenia: A case report.

Catheter Cardiovasc Interv 2018 02 25;91(3):E17-E20. Epub 2017 Oct 25.

Division of Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ccd.27368DOI Listing
February 2018

Questioning the safety and benefits of evolocumab - Authors' reply.

Lancet Diabetes Endocrinol 2018 01;6(1):11-12

TIMI Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S2213-8587(17)30403-5DOI Listing
January 2018

Prevention of Stroke with the Addition of Ezetimibe to Statin Therapy in Patients With Acute Coronary Syndrome in IMPROVE-IT (Improved Reduction of Outcomes: Vytorin Efficacy International Trial).

Circulation 2017 Dec 30;136(25):2440-2450. Epub 2017 Sep 30.

TIMI Study Group, Department of Medicine, Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA (E.A.B., S.D.W., R.P.G., J.-G.P., S.A.M., C.P.C., E.B.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/CIRCULATIONAHA.117.029095DOI Listing
December 2017

Effects of Anacetrapib in Patients with Atherosclerotic Vascular Disease.

N Engl J Med 2017 09 28;377(13):1217-1227. Epub 2017 Aug 28.

Clinical Trial Service Unit and Medical Research Council Population Health Research Unit, University of Oxford, Oxford, United Kingdom

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1706444DOI Listing
September 2017

Dual antiplatelet therapy in patients with diabetes and acute coronary syndromes managed without revascularization.

Am Heart J 2017 Jun 27;188:156-166. Epub 2017 Mar 27.

Duke Clinical Research Institute, Durham, NC, USA; Division of Cardiology, Department of Medicine, Duke University School of Medicine, Durham, NC, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ahj.2017.03.015DOI Listing
June 2017

Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease.

N Engl J Med 2017 05 17;376(18):1713-1722. Epub 2017 Mar 17.

From the Thrombolysis in Myocardial Infarction (TIMI) Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston (M.S.S., R.P.G., S.D.W., S.A.M., J.F.K.); Sydney Medical School, National Health and Medical Research Council Clinical Trials Centre, University of Sydney, Sydney (A.C.K.); Amgen, Thousand Oaks, CA (N.H., H.W., T.L., S.M.W.); International Centre for Circulatory Health, National Heart and Lung Institute, Imperial College London, London (P.S.S.); and Oslo University Hospital, Ullevål and Medical Faculty, University of Oslo, Oslo (T.R.P.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1615664DOI Listing
May 2017

Prasugrel Versus Ticagrelor: Uncertainty Remains.

Circulation 2016 11;134(21):1613-1616

From TIMI Study Group, Brigham and Women's Hospital Heart & Vascular Center, Boston, MA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/CIRCULATIONAHA.116.025113DOI Listing
November 2016

Race and Sex Differences in Management and Outcomes of Patients After ST-Elevation and Non-ST-Elevation Myocardial Infarct: Results From the NCDR.

Clin Cardiol 2016 Oct 28;39(10):585-595. Epub 2016 Jul 28.

Cardiovascular Division, Department of Medicine, Brigham and Women's Hospital, and Harvard Medical School, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/clc.22570DOI Listing
October 2016

Association Between Lowering LDL-C and Cardiovascular Risk Reduction Among Different Therapeutic Interventions: A Systematic Review and Meta-analysis.

JAMA 2016 Sep;316(12):1289-97

TIMI Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jama.2016.13985DOI Listing
September 2016

Diabetes mellitus, CYP2C19 genotype, and response to escalating doses of clopidogrel. Insights from the ELEVATE-TIMI 56 Trial.

Thromb Haemost 2016 07 24;116(1):69-77. Epub 2016 Mar 24.

Marc S. Sabatine, MD, MPH, Brigham & Women's Hospital, 75 Francis Street, Boston, MA 02115, USA, E-mail:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1160/TH15-12-0981DOI Listing
July 2016

Sudden Cardiac Death in Patients With Atrial Fibrillation: Insights From the ENGAGE AF-TIMI 48 Trial.

J Am Heart Assoc 2016 07 8;5(7). Epub 2016 Jul 8.

TIMI Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital, Boston, MA Department of Medicine, Harvard Medical School, Boston, MA

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/JAHA.116.003735DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5015407PMC
July 2016

DAPT Score Utility for Risk Prediction in Patients With or Without Previous Myocardial Infarction.

J Am Coll Cardiol 2016 May 1;67(21):2492-502. Epub 2016 Apr 1.

Harvard Medical School, Boston, Massachusetts; Harvard Clinical Research Institute, Boston, Massachusetts; Department of Cardiovascular Medicine, Brigham and Women's Hospital, Boston, Massachusetts. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jacc.2016.03.485DOI Listing
May 2016

The China Acute Myocardial Infarction (CAMI) Registry: A national long-term registry-research-education integrated platform for exploring acute myocardial infarction in China.

Am Heart J 2016 May 17;175:193-201.e3. Epub 2015 Apr 17.

Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, China. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ahj.2015.04.014DOI Listing
May 2016

Use of Coronary Computed Tomographic Angiography Findings to Modify Statin and Aspirin Prescription in Patients With Acute Chest Pain.

Am J Cardiol 2016 Feb 18;117(3):319-24. Epub 2015 Nov 18.

Division of Cardiology, Department of Radiology, Cardiac Magnetic Resonance, Positron Emission Tomography, and Computed Tomography Program, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.amjcard.2015.10.052DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5931331PMC
February 2016

Causes of late mortality with dual antiplatelet therapy after coronary stents.

Eur Heart J 2016 Jan 18;37(4):378-85. Epub 2015 Nov 18.

The Christ Hospital Heart and Vascular Center, The Lindner Center for Research and Education, Cincinnati, OH, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/eurheartj/ehv614DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4751218PMC
January 2016

The effect of rivaroxaban on myocardial infarction in the ATLAS ACS 2 - TIMI 51 trial.

Eur Heart J Acute Cardiovasc Care 2015 Oct 15;4(5):468-74. Epub 2014 Oct 15.

TIMI Study Group, Heart & Vascular Center, Brigham and Women's Hospital and Harvard Medical School, USA

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/2048872614554109DOI Listing
October 2015

Clinical evidence for oral antiplatelet therapy in acute coronary syndromes.

Lancet 2015 Jul 14;386(9990):292-302. Epub 2015 Mar 14.

French Alliance for Cardiovascular Clinical Trials, Département Hospitalo-Universitaire FIRE, Assistance Publique-Hôpitaux de Paris Hôpital Bichat, Paris, France; Université Paris-Diderot, Sorbonne Paris Cité, Paris, France; Institut National de la Santé et de la Recherche Médicale INSERM U-1148, Paris, France; National Heart and Lung Institute, Imperial College, Royal Brompton Hospital, London, UK. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S0140-6736(15)60213-6DOI Listing
July 2015

Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes.

N Engl J Med 2015 Jun 3;372(25):2387-97. Epub 2015 Jun 3.

From the Thrombolysis in Myocardial Infarction (TIMI) Study Group, Brigham and Women's Hospital, and Harvard Medical School, Boston (C.P.C., R.P.G., A.M., K.I., E.A.B., S.D.W., E.B.); Duke Clinical Research Institute (DCRI), Durham, NC (M.A.B., J.A.W., C.R., R.M.C.); Montreal Heart Institute, Montreal (P.T.); Vivantes Neukölln Medical Center, Berlin (H.D.); Lady Davis Carmel Medical Center, Haifa, Israel (B.S.L.); Canisius-Wilhelmina Ziekenhuis, Nijmegen (T.O.O.), and the Netherlands Leiden University Medical Center, Leiden (J.W.J.) - both in the Netherlands; Fondazione IRCCS Policlinico San Matteo and University of Pavia, Pavia, Italy (G.M.D.F.); National Institute of Cardiology, Warsaw, Poland (W.R.); and Merck, Kenilworth, NJ (P.D.L., A.M.T., T.A.M.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1410489DOI Listing
June 2015

Long-term use of ticagrelor in patients with prior myocardial infarction.

N Engl J Med 2015 May 14;372(19):1791-800. Epub 2015 Mar 14.

From the Thrombolysis in Myocardial Infarction (TIMI) Study Group, Cardiovascular Division, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston (M.P.B., D.L.B., G.M., M.P.F., K.I., S.A.M., S.D.W., E.B., M.S.S.); the Cardiovascular Division, Department of Medicine, Newark Beth Israel Medical Center, Rutgers-New Jersey Medical School, Newark (M.C.); French Alliance for Cardiovascular Trials, Département Hospitalo-Universitaire Fibrosis, Inflammation, Remodeling, Hôpital Bichat, Assistance Publique-Hôpitaux de Paris, INSERM Unité 1148, and Université Paris-Diderot, Sorbonne Paris Cité - all in Paris (P.G.S.); National Heart and Lung Institute, Royal Brompton Hospital, Imperial College, London (P.G.S.), and Department of Cardiovascular Science, University of Sheffield, Sheffield, United Kingdom (R.F.S.); AstraZeneca, Mölndal, Sweden (E.C.J., O.B., P.H.); Icahn School of Medicine at Mount Sinai, New York (S.B.); Canisius-Wilhelmina Hospital, Nijmegen, the Netherlands (T.O.O.); Postgraduate Medical School, Grochowski Hospital, Warsaw, Poland (A.B.); Montreal Heart Institute, Université de Montréal, Montreal (P.T.); Cardiology Research Center, Moscow (M.R.); Kerckhoff Heart Center, Bad Nauheim, and University of Giessen, Giessen - both in Germany (C.H.); Department of Medicine (Cardiology), Tokai University School of Medicine, Isehara, Japan (S.G.); University Hospital, Jihlavska, Brno, Czech Republic (J.S.); Heart Institute (InCor)-University of São Paulo Medical School, São Paulo (J.C.N.); and the Department of Cardiology, Military Hospital, Budapest, Hungary (R.G.K.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1500857DOI Listing
May 2015

Benefits and Risks of Extended Duration Dual Antiplatelet Therapy After PCI in Patients With and Without Acute Myocardial Infarction.

J Am Coll Cardiol 2015 May 15;65(20):2211-21. Epub 2015 Mar 15.

Harvard Clinical Research Institute, Boston, Massachusetts; Harvard Medical School, Boston, Massachusetts; Brigham and Women's Hospital, Boston, Massachusetts. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jacc.2015.03.003DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4678101PMC
May 2015

Efficacy and safety of evolocumab in reducing lipids and cardiovascular events.

N Engl J Med 2015 Apr 15;372(16):1500-9. Epub 2015 Mar 15.

From the Thrombolysis in Myocardial Infarction (TIMI) Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital, and the Department of Medicine, Harvard Medical School, Boston (M.S.S., R.P.G., S.D.W.); the Carbohydrate and Lipid Metabolism Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg (F.J.R.), and the Division of Lipidology, Department of Medicine, University of Cape Town, Cape Town (D.J.B.) - both in South Africa; the Departments of Epidemiology and Medicine, College of Public Health, University of Iowa, Iowa City (J.R.); the Sections of Cardiovascular Research and Cardiology, Department of Medicine, Baylor College of Medicine, and the Center for Cardiovascular Disease Prevention, Houston Methodist DeBakey Heart and Vascular Center, Houston (C.M.B.); Amgen, Thousand Oaks, CA (R. Somaratne, J.L., S.M.W., R. Scott); Jacksonville Center for Clinical Research, Jacksonville, FL (M.J.K.); and the Metabolic and Atherosclerosis Research Center, Cincinnati (E.A.S.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1500858DOI Listing
April 2015

High-risk coronary plaque at coronary CT angiography is associated with nonalcoholic fatty liver disease, independent of coronary plaque and stenosis burden: results from the ROMICAT II trial.

Radiology 2015 Mar 4;274(3):693-701. Epub 2014 Nov 4.

From the Department of Radiology (S.B.P., M.T.L., T.M., T.L., A.P., B.B.G., Q.A.T., U.H., M.F.), Cardiac MR PET CT Program (S.B.P., M.T.L., T.M., T.L., A.P., B.B.G., Q.A.T., U.H., M.F.), and Cardiology Division (Q.A.T., M.F.), Massachusetts General Hospital and Harvard Medical School, 165 Cambridge St, Suite 400, Boston, MA 02114; Department of Biomedical Imaging and Image-guided Therapy, Medical University of Vienna, Vienna, Austria (S.B.P.); Division of Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Mass (S.D.W.); and Division of Cardiovascular Sciences, National Heart, Lung and Blood Institute, Bethesda, Md (J.L.F.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1148/radiol.14140933DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4455680PMC
March 2015

Risk profile of clinical trial participants--reply.

JAMA 2015 Jan;313(1):94-5

Cardiovascular Division, Brigham and Women's Hospital, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jama.2014.15633DOI Listing
January 2015

Coronary stent thrombosis with vorapaxar versus placebo: results from the TRA 2° P-TIMI 50 trial.

J Am Coll Cardiol 2014 Dec 1;64(22):2309-17. Epub 2014 Dec 1.

TIMI Study Group, Cardiovascular Division, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jacc.2014.09.037DOI Listing
December 2014

New ischemic stroke and outcomes with vorapaxar versus placebo: results from the TRA 2 °P-TIMI 50 trial.

J Am Coll Cardiol 2014 Dec 1;64(22):2318-26. Epub 2014 Dec 1.

TIMI Study Group, Cardiovascular Division, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jacc.2014.07.997DOI Listing
December 2014

Modern obesity pharmacotherapy: weighing cardiovascular risk and benefit.

Clin Cardiol 2014 Nov 15;37(11):693-9. Epub 2014 Sep 15.

TIMI Study Group, Cardiovascular Division, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/clc.22304
Publisher Site
http://dx.doi.org/10.1002/clc.22304DOI Listing
November 2014

Contemporary patterns of discharge aspirin dosing after acute myocardial infarction in the United States: results from the National Cardiovascular Data Registry (NCDR).

Circ Cardiovasc Qual Outcomes 2014 Sep 12;7(5):701-7. Epub 2014 Aug 12.

From the Department of Internal Medicine, Division of Cardiology, University of Texas Southwestern Medical Center, Dallas (H.M.H., J.A.d.L., D.K.M., S.R.D.); Division of Cardiology, University of Missouri-Kansas City (J.R.E.); Duke Clinical Research Institute, Durham, NC (S.A.P., K.P.A., M.T.R.); and Division of Cardiology, Brigham and Women's Hospital, Boston, MA (N.D., S.D.W.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/CIRCOUTCOMES.113.000822DOI Listing
September 2014

Cerebrovascular events in 21 105 patients with atrial fibrillation randomized to edoxaban versus warfarin: Effective Anticoagulation with Factor Xa Next Generation in Atrial Fibrillation-Thrombolysis in Myocardial Infarction 48.

Stroke 2014 Aug 19;45(8):2372-8. Epub 2014 Jun 19.

From the Division of Cardiovascular Medicine, Brigham and Women's Hospital, Boston, MA (R.P.G., C.T.R., S.D.W., C.L., N.D., S.A.M., L.T.G., E.M.A., E.B.); Department of Neurology, Massachusetts General Hospital, Boston (N.S.R., S.S.); Biostatistics, Quintiles, Inc, Durham, NC (J.M.B.); and Daiichi Sankyo, Inc, Pharma Development, Edison, NJ (A.D., J.D., M.S., M.M.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/STROKEAHA.114.006025DOI Listing
August 2014

Clinical trial participation after myocardial infarction in a national cardiovascular data registry.

JAMA 2014 Aug;312(8):841-3

Cardiovascular Division, Brigham and Women's Hospital, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jama.2014.6217DOI Listing
August 2014

Early clopidogrel versus prasugrel use among contemporary STEMI and NSTEMI patients in the US: insights from the National Cardiovascular Data Registry.

J Am Heart Assoc 2014 Apr 14;3(2):e000849. Epub 2014 Apr 14.

Division of Cardiovascular Medicine, Duke University Medical Center, Duke Clinical Research Institute, Durham, NC.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/JAHA.114.000849DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4187510PMC
April 2014

Clinical implications and correlates of Q waves in patients with ST-elevation myocardial infarction treated with fibrinolysis: observations from the CLARITY-TIMI 28 trial.

Clin Cardiol 2014 Mar 22;37(3):160-6. Epub 2014 Jan 22.

TIMI Study Group, Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/clc.22235DOI Listing
March 2014

Influence of presenting electrocardiographic findings on the treatment and outcomes of patients with non-ST-segment elevation myocardial infarction.

Am J Cardiol 2014 Jan 2;113(2):256-61. Epub 2013 Oct 2.

Cardiovascular Section, Department of Medicine, University of Oklahoma Health Science Center, Oklahoma City, Oklahoma. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.amjcard.2013.09.009DOI Listing
January 2014

Balancing the risk of mortality and major bleeding in the treatment of NSTEMI patients - a report from the National Cardiovascular Data Registry.

Am Heart J 2013 Dec 11;166(6):1043-1049.e1. Epub 2013 Oct 11.

TIMI Study Group, Department of Medicine, Division of Cardiovascular Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ahj.2013.09.004DOI Listing
December 2013

Circadian variation of stent thrombosis and the effect of more robust platelet inhibition: a post hoc analysis of the TRITON-TIMI 38 trial.

J Cardiovasc Pharmacol Ther 2013 Nov 24;18(6):555-9. Epub 2013 Sep 24.

1Cardiology Division, University of Texas Southwestern Medical School, Dallas, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1074248413497534DOI Listing
November 2013

Edoxaban versus warfarin in patients with atrial fibrillation.

N Engl J Med 2013 Nov 19;369(22):2093-104. Epub 2013 Nov 19.

From Brigham and Women's Hospital and Harvard Medical School, Boston (R.P.G., C.T.R., E.B., S.A.M., S.D.W., L.T.G., E.M.A.); Mount Sinai Medical Center, New York (J.L.H.); University Hospitals Case Medical Center, Cleveland (A.L.W.); Thomas Jefferson Medical College, Philadelphia (M.D.E.); McMaster University, Hamilton, ON, Canada (J.I.W.); University Hospital, Jihlavska, Brno, Czech Republic (J.S.); Institute of Cardiology, Warsaw, Poland (W.R.); Cardiology Research Center, Moscow (M.R.); National Hospital Organization, Osaka National Hospital, Osaka, Japan (Y.K.); Quintiles, Durham, NC (J.B., S.P.P.); and Daiichi Sankyo Pharma Development, Edison, NJ (M.S., I.P., J.J.H., M.M.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1310907DOI Listing
November 2013

Association between natriuretic peptides and mortality among patients admitted with myocardial infarction: a report from the ACTION Registry(R)-GWTG™.

Clin Chem 2013 Aug 29;59(8):1205-14. Epub 2013 Apr 29.

TIMI Study Group, Cardiovascular Division, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1373/clinchem.2012.198556DOI Listing
August 2013

Comparison of the efficacy and safety of two rivaroxaban doses in acute coronary syndrome (from ATLAS ACS 2-TIMI 51).

Am J Cardiol 2013 Aug 24;112(4):472-8. Epub 2013 May 24.

TIMI Study Group, Cardiovascular Division, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.amjcard.2013.04.011DOI Listing
August 2013

Circadian variation in patient characteristics and outcomes in ST-segment elevation myocardial infarction.

Chronobiol Int 2012 Dec 6;29(10):1390-6. Epub 2012 Nov 6.

Division of Cardiology, University of Texas-Southwestern Medical School, 5323 Harry Hines Boulevard, Dallas, TX 75390-8830, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/07420528.2012.728658DOI Listing
December 2012

Atopaxar and its effects on markers of platelet activation and inflammation: results from the LANCELOT CAD program.

J Thromb Thrombolysis 2012 Jul;34(1):36-43

Cardiovascular Division and TIMI Study Group, Brigham and Women's Hospital, 350 Longwood Avenue, 1st floor, Boston, MA 02115, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11239-012-0750-6DOI Listing
July 2012

Vorapaxar in the secondary prevention of atherothrombotic events.

N Engl J Med 2012 Apr 24;366(15):1404-13. Epub 2012 Mar 24.

Thrombolysis in Myocardial Infarction (TIMI) Study Group, Cardiovascular Division, Department of Medicine, Brigham and Women's Hospital, Boston, MA 02115, USA.

View Article

Download full-text PDF

Source
http://www.nejm.org/doi/abs/10.1056/NEJMoa1200933
Publisher Site
http://dx.doi.org/10.1056/NEJMoa1200933DOI Listing
April 2012

Short-term outcomes of acute myocardial infarction in patients with acute kidney injury: a report from the national cardiovascular data registry.

Circulation 2012 Jan 16;125(3):497-504. Epub 2011 Dec 16.

NHLBI's Framingham Heart Study, Division of Intramural Research, NHLBI, 73 Mt Wayte Ave, Ste 2, Framingham, MA 01702, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/CIRCULATIONAHA.111.039909DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3411118PMC
January 2012